Home Investing RAD Granted US FDA Fast Track for RAD101 Metastases Imaging
Investing

RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

by

Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterPinterestEmail

Related Posts

Top 5 Canadian Mining Stocks This Week: St....

Crypto Market Recap: Stablecoin Market Makes Headway, SharpLink...

Editor’s Picks: Trump to Lift Minnesota Mining Ban,...

Brunswick Exploration Announces AGM Results

Harvest Gold Announces Annual General Meeting Results

Grande Portage Closes Non-Brokered Private Placement Pursuant to...

Disclaimer: smartearns.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 smartearns.com | All Rights Reserved